- Title
- p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53
- Creators
- Pellegrino G Magro - Joan and Sanford 1, Weill Graduate School of Medical Sciences of Cornell University, New York, New York, United StatesAngelo J Russo - Joan and Sanford 1, Weill Graduate School of Medical Sciences of Cornell University, New York, New York, United StatesWei-Wei LI - Memorial Sloan Kettering Cancer Center, New York, New York, United StatesDebabrata Banerjee - The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United StatesJoseph R Bertino - The Cancer Institute of New Jersey, Robert Wood Johnson Medical School, New Brunswick, New Jersey, United States
- Publication Details
- Cancer research (Chicago, Ill.), Vol.64(12), pp.4338-4345
- Date published
- 2004
- Publisher
- American Association for Cancer Research
- Academic Unit
- Bertino Office; Pharmacology (RWJMS)
- Language
- English
- Resource Type
- Journal article
- Identifiers
- 991031665738604646
Journal article
p14ARF expression increases dihydrofolate reductase degradation and paradoxically results in resistance to folate antagonists in cells with nonfunctional p53
Cancer research (Chicago, Ill.), Vol.64(12), pp.4338-4345
2004
PMID: 15205349
Metrics
7 Record Views